Literature DB >> 2886911

Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus.

R Verham, T D Meek, L Hedstrom, C C Wang.   

Abstract

The IMP dehydrogenase of Tritrichomonas foetus, a parasitic protozoan incapable of de novo biosynthesis of purine nucleotides, has been purified about 1000-fold to apparent homogeneity. The purified enzyme demonstrated a 20-fold higher substrate turnover rate than the pure IMP dehydrogenase from sarcoma ascites tumor cells. It has a subunit molecular weight of 58,000, aggregates to a size of 380,000 at low ionic strength, and partly dissociates to a molecular weight of 270,000 in high salt concentrations. Unlike the IMP dehydrogenase of bacteria and mammals, the T. foetus enzyme does not require K+ for activity. The analysis of initial velocity and product inhibition data is consistent with a sequential, ordered bi bi kinetic mechanism for the parasite enzyme-catalyzed reaction, in which IMP binds before NAD+ and NADH is released before XMP. This is in contrast to the partially random mechanism of the bacterial enzyme which involves the formation of an enzyme-K+-(IMP) complex. Mycophenolic acid inhibits T. foetus IMP dehydrogenase uncompetitively versus both IMP and NAD+ with an apparent Ki of 9 microM. This value, which is several hundred-fold higher than that for mammalian IMP dehydrogenase, suggests significantly different binding properties of the mycophenolic acid site in T. foetus IMP dehydrogenase, which might be amenable to specific inhibitor design.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886911     DOI: 10.1016/0166-6851(87)90110-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Oxanosine Monophosphate Is a Covalent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase.

Authors:  Runhan Yu; Youngchang Kim; Natalia Maltseva; Philip Braunstein; Andrzej Joachimiak; Lizbeth Hedstrom
Journal:  Chem Res Toxicol       Date:  2019-02-25       Impact factor: 3.739

Review 3.  The design and development of an immunosuppressive drug, mycophenolate mofetil.

Authors:  A C Allison; E M Eugui
Journal:  Springer Semin Immunopathol       Date:  1993

Review 4.  Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.

Authors:  W D Simmons; S C Rayhill; H W Sollinger
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

5.  Purification and preliminary characterization of (E)-3-(2,4-dioxo-6-methyl-5-pyrimidinyl)acrylic acid synthase, an enzyme involved in biosynthesis of the antitumor agent sparsomycin.

Authors:  R J Parry; J C Hoyt
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

6.  IMP dehydrogenase from the protozoan parasite Toxoplasma gondii.

Authors:  William J Sullivan; Stacy E Dixon; Catherine Li; Boris Striepen; Sherry F Queener
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  The raspberry locus encodes Drosophila inosine monophosphate dehydrogenase.

Authors:  R Slee; M Bownes
Journal:  Mol Gen Genet       Date:  1995-10-25

8.  Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.

Authors:  C Alfieri; A C Allison; E Kieff
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.